EraGen Biosciences has appointed Samraat Raha Chief Business Officer, the Madison, Wis.-based company said last week. Raha will be responsible for EraGen’s overall business development, sales, and marketing efforts. In his most recent position, Raha served as vice president of discovery services at Incyte Genomics, where he oversaw the company’s genomic service businesses, including microarrays and bioreagents. Raha has a BA in molecular and cell biology from the University of California, Berkeley.
After leaving the Australian Proteomics Analysis Facility earlier this year, Brad Walsh has started his own company, ProteoMeca. Walsh will serve as CEO of the new proteomics discovery company, which is planning to apply proteomics to agriculture and bacterial systems. ProteoMeca is based in Harbord, Australia.
Grant Cameron has joined Cambridge, UK-based NextGen Sciences as European Commercial Director. Cameron previously served as business director for Sense Proteomic.